Companies/US/OCUL

OCULAR THERAPEUTIX, INC.

Income flow

Annual
OCUL 10-K Income StatementPeriod 2024-12-31Source 10-K
Net sales$64M+9% Y/YRevenue$64M+9% Y/YGross profit$58M+9% Y/YCost of revenue$6M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0Shares outTotal shares currently outstanding (issued and not retired).219.6MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).184.7M